Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Sep 8;8(12):2869-2873.
doi: 10.1002/ccr3.3310. eCollection 2020 Dec.

Light-chain amyloid myopathy isolated to skeletal muscles: A case report

Affiliations
Case Reports

Light-chain amyloid myopathy isolated to skeletal muscles: A case report

Toshihiro Matsukawa et al. Clin Case Rep. .

Abstract

Isolated amyloidosis, especially of amyloid light-chain type, is an infrequent disease. Systemic chemotherapy for light-chain amyloidosis isolated to skeletal muscles plays a key role to reduce clonal plasma cells producing aberrant immunoglobulin.

Keywords: amyloidosis; isolated amyloid myopathy; light‐chain.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

Figure 1
Figure 1
Representative pathological images of a rectus femoris muscle biopsy. On hematoxylin and eosin (A), fiber size variation is mild. On nicotinamide adenine dinucleotide tetrazolium reductase (B), intermyofibrillar network is mildly disorganized in some fibers. On Congo red (C), amyloid is deposited in the area surrounding muscle fibers. Scale bars: 100 μm
Figure 2
Figure 2
Leg muscle imaging. Computerized tomography (CT) (A), T2‐weighted short‐tau inversion recovery magnetic resonance imaging (MRI) (B). CT and MRI scans did not show any abnormalities
Figure 3
Figure 3
Clinical course from the diagnosis. The green arrow shows auto peripheral blood stem cell transplantation. The number in a colored block represents the number of cycles of chemotherapy. VRD, bortezomib, lenalidomide, and dexamethasone; HDCY, high‐dose cyclophosphamide; HDM, high‐dose melphalan; ELd, elotuzumab, lenalidomide, and dexamethasone; CK, creatine kinase; FLC, free light‐chain

References

    1. Rambaran RN, Serpell LC. Amyloid fibrils: abnormal protein assembly. Prion. 2008;2(3):112‐117. - PMC - PubMed
    1. Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538‐e548. - PubMed
    1. Prayson RA. Amyloid myopathy: clinicopathologic study of 16 cases. Hum Pathol. 1998;29(5):463‐468. - PubMed
    1. Perfetti V, Palladini G, Casarini S, et al. The repertoire of lambda light chains causing predominant amyloid heart involvement and identification of a preferentially involved germline gene, IGLV1‐44. Blood. 2012;119(1):144‐150. - PubMed
    1. Kourelis TV, Dasari S, Theis JD, et al. Clarifying immunoglobulin gene usage in systemic and localized immunoglobulin light‐chain amyloidosis by mass spectrometry. Blood. 2017;129(3):299‐306. - PubMed

Publication types

LinkOut - more resources